NeoPharm CO., LTD. (092730.KQ)
KRW 12830.0
(0.39%)
KRW 12830.0
(0.39%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 23.21 Billion KRW | 36.33% |
| 2022 | 17.02 Billion KRW | -3.87% |
| 2021 | 17.71 Billion KRW | -2.3% |
| 2020 | 18.13 Billion KRW | -5.79% |
| 2019 | 19.24 Billion KRW | 25.22% |
| 2018 | 15.36 Billion KRW | 32.96% |
| 2017 | 11.55 Billion KRW | 49.3% |
| 2016 | 7.74 Billion KRW | 127.24% |
| 2015 | 3.4 Billion KRW | 0.0% |
| 2014 | 2.56 Billion KRW | N/A |
| 2013 | 1.89 Billion KRW | N/A |
| 2012 | 647.76 Million KRW | 0.0% |
| 2011 | 904.24 Million KRW | N/A |
| 2010 | 1.29 Billion KRW | N/A |
| 2009 | 2.05 Billion KRW | N/A |
| 2008 | 3.28 Billion KRW | N/A |
| 2007 | 1.79 Billion KRW | N/A |
| 2006 | 3.5 Billion KRW | N/A |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 6.11 Billion KRW | 1.8% |
| 2024 Q3 | 4.33 Billion KRW | -26.31% |
| 2024 Q2 | 5.88 Billion KRW | -3.75% |
| 2023 Q1 | 6.8 Billion KRW | 93.2% |
| 2023 Q4 | 6 Billion KRW | 21.75% |
| 2023 FY | 23.21 Billion KRW | 36.33% |
| 2023 Q2 | 5.46 Billion KRW | -19.67% |
| 2023 Q3 | 4.93 Billion KRW | -9.84% |
| 2022 Q2 | 4.59 Billion KRW | -6.59% |
| 2022 Q4 | 3.52 Billion KRW | -11.45% |
| 2022 FY | 17.02 Billion KRW | -3.87% |
| 2022 Q3 | 3.97 Billion KRW | -13.48% |
| 2022 Q1 | 4.92 Billion KRW | 3.85% |
| 2021 Q4 | 4.74 Billion KRW | 52.73% |
| 2021 Q3 | 3.1 Billion KRW | -24.91% |
| 2021 FY | 17.71 Billion KRW | -2.3% |
| 2021 Q2 | 4.13 Billion KRW | -27.87% |
| 2021 Q1 | 5.73 Billion KRW | 9.48% |
| 2020 Q2 | 4.55 Billion KRW | -15.56% |
| 2020 FY | 18.13 Billion KRW | -5.79% |
| 2020 Q4 | 5.23 Billion KRW | 77.09% |
| 2020 Q1 | 5.38 Billion KRW | -7.72% |
| 2020 Q3 | 2.95 Billion KRW | -35.02% |
| 2019 FY | 19.24 Billion KRW | 25.22% |
| 2019 Q4 | 5.83 Billion KRW | 40.47% |
| 2019 Q1 | 4.73 Billion KRW | 2.98% |
| 2019 Q2 | 4.51 Billion KRW | -4.57% |
| 2019 Q3 | 4.15 Billion KRW | -7.96% |
| 2018 Q1 | 4.3 Billion KRW | 48.1% |
| 2018 FY | 15.36 Billion KRW | 32.96% |
| 2018 Q3 | 2.82 Billion KRW | -22.2% |
| 2018 Q2 | 3.63 Billion KRW | -15.55% |
| 2018 Q4 | 4.59 Billion KRW | 62.42% |
| 2017 Q1 | 3.35 Billion KRW | 188.32% |
| 2017 FY | 11.55 Billion KRW | 49.3% |
| 2017 Q2 | 3.04 Billion KRW | -9.14% |
| 2017 Q3 | 2.25 Billion KRW | -26.04% |
| 2017 Q4 | 2.9 Billion KRW | 29.09% |
| 2016 Q3 | 1.8 Billion KRW | 1.58% |
| 2016 FY | 7.74 Billion KRW | 127.24% |
| 2016 Q2 | 1.77 Billion KRW | -40.76% |
| 2016 Q4 | 1.16 Billion KRW | -35.56% |
| 2016 Q1 | 2.99 Billion KRW | 579.65% |
| 2015 Q2 | 830.01 Million KRW | 0.0% |
| 2015 FY | 3.4 Billion KRW | 0.0% |
| 2015 Q3 | 1.26 Billion KRW | 52.82% |
| 2015 Q4 | -625.22 Million KRW | -149.29% |
| 2013 Q2 | 1.14 Billion KRW | 25.1% |
| 2013 Q1 | 913.49 Million KRW | 1725.29% |
| 2013 Q3 | -631.28 Million KRW | -155.24% |
| 2012 Q4 | 50.04 Million KRW | 0.0% |
| 2012 FY | 647.76 Million KRW | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Kolmar BNH Co., Ltd. | 19.7 Billion KRW | -17.773% |